Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726318 · ClinicalTrials.gov registry record · Phase 4
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
A Phase 4 study of UTI, sponsored by Megan Bradley.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05726318: Completed Phase 4 study of UTI, sponsored by Megan Bradley.
NCT05726318 is a Phase 4 study of UTI that has completed, run by Megan Bradley. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05726318, a Phase 4 study of UTI, has completed, sponsored by Megan Bradley.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.
Primary Outcome
Number and proportion of eligible subjects that were enrolled in the study
Conditions Studied
Interventions
- DRUG Antibiotics
Study Locations (1)
Pennsylvania
- Magee Women's Hospital of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2024-08-02 |
| Phase | Phase 4 |
What the finished NCT05726318 record still lists
NCT05726318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 1 condition, with UTI appearing as the primary indexed condition, and to 1 intervention - of which Antibiotics is the first listed.
NCT05726318 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05726318 about?
NCT05726318 is a clinical study titled "Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women". To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.
What is the current status of trial NCT05726318?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2023-02-17. Estimated completion is 2024-08-02.
What conditions does trial NCT05726318 study?
This clinical trial studies the following conditions: UTI.
What interventions are being tested in trial NCT05726318?
The interventions under investigation include: Antibiotics (DRUG).
Who is sponsoring clinical trial NCT05726318?
This trial is sponsored by Megan Bradley, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05726318 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for UTI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05726318's enrollment target sits among peer trials
70 1043rd of 2000 higher than 932 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI